Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis.
Alegre-Sancho JJ, Núñez-Monje V, Campos-Fernández C, Balaguer-Trull I, Robustillo-Villarino M, Aguilar-Zamora M, Garijo-Bufort M, Pedraz-Penalva T, Peña-González C, de la Morena I, Bedoya-Sanchís D, Yankova-Komsalova L, Conesa-Mateos A, Martinez-Cristóbal A, Navarro-Blasco FJ, Senabre-Gallego JM, Sivera F. Alegre-Sancho JJ, et al. Among authors: balaguer trull i. Front Med (Lausanne). 2023 Nov 20;10:1294247. doi: 10.3389/fmed.2023.1294247. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38053615 Free PMC article.
Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum.
Sivera F, Núñez-Monje V, Campos-Fernández C, Balaguer-Trull I, Robustillo-Villarino M, Aguilar-Zamora M, Garijo-Bufort M, López-Gómez JM, Peña-González C, de la Morena I, Bedoya-Sanchís D, Yankova-Komsalova L, Conesa-Mateos A, Martínez-Cristóbal A, Navarro-Blasco FJ, Senabre-Gallego JM, Alegre-Sancho JJ. Sivera F, et al. Among authors: balaguer trull i. Front Med (Lausanne). 2023 May 11;10:1156557. doi: 10.3389/fmed.2023.1156557. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37250652 Free PMC article.
Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab.
Lerma Garrido JJ, Gracia Pérez A, Pérez Torres A, Rueda Cid A, Molina Almela C, Pastor Cubillo MD, Campos Fernández C, Balaguer Trull I, Carmona L, Calvo Catalá J. Lerma Garrido JJ, et al. Among authors: balaguer trull i. Reumatol Clin (Engl Ed). 2020 Sep 26:S1699-258X(20)30194-7. doi: 10.1016/j.reuma.2020.07.010. Online ahead of print. Reumatol Clin (Engl Ed). 2020. PMID: 32994150 Free article. English, Spanish.